The monocyte transcriptome during pregnancy in multiple sclerosis: Prominent expression of the Fc-receptor CD64
Background: During the third trimester of pregnancy multiple sclerosis (MS) disease activity is reduced. It is not fully understood which factors mediate this disease amelioration. Objective: To study alterations of the monocyte transcriptome during pregnancy in MS patients, using a genomewide approach to identify differentially regulated genes. Methods: Women with MS and healthy controls were longitudinally studied, including a visit before pregnancy. Results: RNA-microarray analysis was performed in six patients. We found a significant increase of CD64 (Fc gamma receptor 1a, FcgR1a) during the third trimester compared with baseline, confirmed by RT-PCR in a group of ten patients. Analysis with Ingenuity software was performed using all genes expression of which was altered at least 1.5-fold in at least five out of six patients. Major networks that were altered during MS pregnancy were: cell-to-cell signalling and interaction, immune response, and cell signalling. From the genes selected for Ingenuity analysis, seven additional candidate genes, selected for their biological interest, were tested using RT-PCR in ten patients with MS and nine controls. We found an increased expression of JAK2 and STAT1 directly postpartum in patients with MS and in controls. Conclusion: The increased CD64 expression during pregnancy is indicative of enhanced innate immune functions.
|Keywords||CD64, autoimmunity, immune tolerance, innate immunity, multiple sclerosis, pregnancy|
|Persistent URL||dx.doi.org/10.1177/1352458510389628, hdl.handle.net/1765/26487|
Neuteboom, R.F., Verbraak, E., Wierenga-Wolf, A.F., Voerman, J.S., van Meurs, M., Swagemakers, S.M.A., … Hintzen, R.Q.. (2011). The monocyte transcriptome during pregnancy in multiple sclerosis: Prominent expression of the Fc-receptor CD64. Multiple Sclerosis: clinical and laboratory research, 17(4), 389–396. doi:10.1177/1352458510389628